Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Raffles Family Office is building a wealth manager for Asia’s stablecoin billionaires

Younger billionaires are more likely to store their wealth on the blockchain.

Raffles Family Office is building a wealth manager for Asia’s stablecoin billionaires

Raffles Family Office (RFO), a firm specializing in wealth management for Asia's emerging billionaires, is developing a digital assets-focused division to serve clients with substantial holdings in stablecoins. With younger self-made billionaires in Asia managing their wealth through digital currencies like Bitcoin and Ethereum, traditional finance institutions have struggled to accommodate these assets.

In 2022, RFO launched Revo, a digital assets-focused multi-family office, and obtained licenses from Hong Kong's Securities and Futures Commission to offer professional portfolio management for digital assets. A 2026 survey revealed that 86% of family offices have begun incorporating crypto assets into their investment strategies, despite regulatory and reporting challenges.

RFO, which currently serves high-net-worth individuals across six Asian cities, has recently expanded its reach to Kigali, Rwanda, by co-hosting a family office symposium and appointing a principal to drive investment flows between Asia and Africa. Kwan predicts that Africa could overtake Asia as the world's fastest-growing continent by 2050, driven by a growing African population and increased earning and spending power.

Written by urgent.news from Fortune's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at fortune.com →

More in Finance & Markets

Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?

One of these pharma stocks offers more income, but the other offers a safer dividend.

  • Pfizer offers 5.8% forward dividend yield, higher than Bristol Myers Squibb's 4.3%
  • Bristol Myers Squibb has 17-year streak of dividend increases, 94 years total
  • Pfizer's higher yield and cash flow meet obligations despite payout ratio >100%

More from Friday 23 October →